Argenica Therapeutics (ASX:AGN) FCF Yield % : -4.23 (As of May. 25, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Argenica Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Argenica Therapeutics's Trailing 12-Month Free Cash Flow is A$-3.66 Mil, and Market Cap is A$86.59 Mil. Therefore, Argenica Therapeutics's FCF Yield % for today is -4.23%.

The historical rank and industry rank for Argenica Therapeutics's FCF Yield % or its related term are showing as below:

ASX:AGN' s FCF Yield % Range Over the Past 10 Years
Min: -10.92 Med: 0 Max: 0
Current: -4.23

ASX:AGN's FCF Yield % is ranked better than
73.55% of 1554 companies
in the Biotechnology industry
Industry Median: -14.35 vs ASX:AGN: -4.23

Argenica Therapeutics's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

Argenica Therapeutics FCF Yield % Historical Data

The historical data trend for Argenica Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Argenica Therapeutics FCF Yield % Chart

Argenica Therapeutics Annual Data

Trend

Jun21

Jun22

Jun23

FCF Yield %

-7.15

-8.99

-8.95

Argenica Therapeutics Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial			-5.99	-8.20	-3.99	-13.66	-4.50

Competitive Comparison of Argenica Therapeutics's FCF Yield %

For the Biotechnology subindustry, Argenica Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Argenica Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Argenica Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Argenica Therapeutics's FCF Yield % falls into.

Argenica Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Argenica Therapeutics's FCF Yield % for the fiscal year that ended in Jun. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-3.3	/	36.88155
	=	-8.95%

Argenica Therapeutics's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-1.137	*	2	/	50.566908
	=	-4.50%

Argenica Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Argenica Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Argenica Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Argenica Therapeutics (ASX:AGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Argenica Therapeutics Ltd (ASX:AGN) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

117 Broadway, Unit 4, Nedlands, WA, AUS, 6009

Website

https://www.argenica.com.au

Argenica Therapeutics Ltd is engaged in the development and commercialization of novel drug candidates. Its ARG007 drug improves outcomes in pre-clinical stroke models and is in the process of being verified for its safety and toxicology before commencing Phase 1 clinical trials in humans.

Argenica Therapeutics (ASX:AGN) Headlines

No Headlines